Remove Bioinformatics Remove Drug Research Remove Marketing
article thumbnail

Accelerating Drug Discovery Through Repurposing

DrugBank

In Silico Drug Repurposing Advances in bioinformatics and systems biology have fueled the rise of repurposing of in silico drugs. CMap utilizes gene expression profiles to connect drugs, genes, and diseases, enabling researchers to identify potential repurposing candidates based on their transcriptional signatures.

article thumbnail

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

The financial burden of drug development is substantial, often exceeding $2 billion per drug. Given that only a fraction of early-stage drug candidates progress to market, the costs associated with these failures are inevitably absorbed into the overall development costs.